NCT05569512 2024-08-19Uproleselan With Pre-Transplant Conditioning in Hematopoietic Stem Cell Transplantation for AMLDana-Farber Cancer InstitutePhase 1 Terminated1 enrolled
NCT00983528 2020-08-12Alemtuzumab and Clofarabine for Relapsed or Refractory Acute Lymphoblastic LeukemiaUniversity of California, San DiegoPhase 1/2 Terminated6 enrolled 6 charts
NCT00857389 2020-04-07Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk MalignanciesM.D. Anderson Cancer CenterPhase 2 Completed60 enrolled 15 charts
NCT00617929 2017-12-28Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell TransplantMasonic Cancer Center, University of MinnesotaPhase 2 Terminated12 enrolled 12 charts
NCT00708721 2017-06-01Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic LeukemiaUniversity of UtahPhase 1/2 Terminated11 enrolled 11 charts
NCT00477542 2014-09-18A Phase I Trial of Myeloablative Conditioning w/ Clofarabine and HD Busulfan for Pts w/ Refractory Heme Malignancies Undergoing Allo PBSCTIndiana UniversityPhase 1 Completed18 enrolled